Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Anika Therapeutics Inc. (ANIK)

ADC Therapeutics SA and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $258.7M against $209.4M — 1.2× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against 3.03%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −121.8%) and the lower return on invested capital (−3.24% vs 0.00%). Across the 17 metrics below, Anika Therapeutics Inc. leads on 10 and ADC Therapeutics SA on 7.

Valuation

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 2.13 2.08
P/B n/m 1.88 1.79
Price to free cash flow n/m 458.01 16.29
EV/EBITDA n/m 476.54 12.22
EV/Sales 1.95 2.02 2.87
Earnings yield (39.76%) (1.35%) (15.94%)
Free cash flow yield (39.53%) 0.22% 0.00%

Profitability

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 62.16% 53.51%
Operating margin (125.08%) (4.24%) 0.00%
Net margin (121.77%) (3.14%) (2.45%)
Free cash flow margin (127.72%) 0.47% 0.00%
Return on equity 45.35% (2.66%) (0.80%)
Return on assets (32.25%) (2.04%) (1.67%)
Return on invested capital 0.00% (3.24%) 0.00%

Growth

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% 5.33% 5.22%
EPS growth (last fiscal year) 30.86% 80.16% 42.91%
Revenue growth, 5-year CAGR 103.35% (2.86%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.00 0.04
Current ratio 3.03 4.48 2.41
Net debt to EBITDA 1.22 10.80 1.01

Dividend

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT ANIK Drug Manufacturers Specialty & Generic median
Market cap 209.38m 258.69m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack